Dasatinib Monohydrate: A Targeted Therapy for Leukemia

Discover the efficacy and applications of Dasatinib Monohydrate in advanced cancer treatment.

Get a Quote & Sample

Key Advantages

Targeted Action

This tyrosine kinase inhibitor offers a targeted approach, minimizing damage to healthy cells while effectively combating cancer. Its mechanism is crucial for effective leukemia treatment.

Clinical Efficacy

Numerous studies highlight the efficacy of Dasatinib Monohydrate API in improving outcomes for patients with CML and Ph+ ALL, offering new hope in cancer medicine.

Pharmaceutical Grade

The Dasatinib Monohydrate pharmaceutical grade ensures high purity and quality, essential for its application as an active pharmaceutical ingredient in critical treatments.

Key Applications

Chronic Myeloid Leukemia (CML) Treatment

Utilized for adults and children with CML, especially those resistant or intolerant to other therapies, demonstrating its role in specific CML treatment protocols.

Acute Lymphoblastic Leukemia (ALL) Treatment

An important component in treating Ph+ ALL, it offers a crucial therapeutic option for patients requiring advanced ALL treatment.

Oncology Research and Development

Serves as a key compound in ongoing cancer drug development and research into novel therapeutic strategies.

Pharmaceutical Intermediate Supply

Supplied as a high-quality intermediate, it is essential for the manufacturing of life-saving medications in the pharmaceutical intermediate sector.